More IPOs need to deliver listing pop to revive retail interest: Analysts

Analysts say retail investors' enthusiasm fizzled out post the muted listing of a majority of public offers in CY22

Nikita VashishtPuneet Wadhwa New Delhi
More IPOs need to deliver listing pop to revive retail interest: Analysts
Web Exclusive Premium

Listen to This Article

The primary market has remained subdued so far in calendar year 2023 (CY23) with just three mainboard initial public offers (IPOs) hitting the Street -- Divgi TorqTransfer System, Avalon Technologies, and Mankind Pharma.
Two of these three IPOs, however, failed to generate interest among retail investors, who have been at the forefront of the primary market activity since 2020.
Mankind Pharma's IPO, for instance, saw 92 per cent subscription by retail investors, while Avalon Tech's retail quota was subscribed 88 per cent.


Also Read

Mankind Pharma IPO to open next week: Check price band, GMP, other details

Mankind Pharma IPO opens today: Check GMP, price band, other details here

Sensex, Nifty end flat after choppy day; Indiabulls RE sinks 20%, Zomato 6%

Mankind Pharma IPO subscribed 8% so far on Day 1; GMP down 30% in 10 days

Is Mankind Pharma IPO worth a subscription? Here's what brokerages suggest

Lupin extends gain, hits 52-wk high post Q4 results; surges 20% in 1 month

Adani Group shares trade weak in a firm market; decline up to 5%

DLF rallies 5%; hits multi-year high on healthy March quarter results

Adani stocks have seasonality to help in recovery from $100 billion rout

Avenue Supermarts slips 5% on subdued Q4 operational performance

Mankind Pharma

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 5Y
  • MAX

First Published: May 15 2023 | 11:39 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to